This is an overview of the USAID/Afghanistan FY 2024 Tuberculosis (TB) Roadmap, implemented with the FY 2023 budget. The roadmap was developed in consultation with the USAID/Afghanistan implementing partners (IPs) and national and international TB stakeholders involved in TB prevention and care in the country.

TABLES

The following tables illustrate the distribution by technical area of the USAID TB budget for Afghanistan that will be used for the implementation of Afghanistan’s FY23 TB Roadmap (Table 1) and the core indicators that will be used to monitor implementation of Afghanistan’s TB Roadmap and the country's progress towards the United Nations General Assembly High-Level Meeting on TB targets (UNGA targets) (Table 2).

Table 1: USAID Budget for Afghanistan per Technical Area*

Technical AreaUSAID TB budgetUSAID Percentage of TB budget
REACH$3,100,000 51.67%
CURE$1,940,000 32.33%
PREVENT$600,000 10%
SUSTAIN$360,0006.00%
TOTAL BUDGET:$6,000,000100%

Table 2: TB Core Indicators in Afghanistan from 2016-2022 and Targets for 2023

#Name20162017201820192020202120222023*
REACH: Increased DS- and DR-TB case notification
1TB Detection63%68%69%73%62%68%60%73%
2Bacteriological Diagnosis Coverage (Pulmonary TB)63%61%64%64%68%67%68%-
3Childhood TB Notifications6,3659,73210,46011,4749,73811,22011,62215,248
4Drug-Resistant TB Notifications156284480491424582644919
5Private Sector TB Notifications6,0893,1803,3874,2764,8436,0075,886-
6Contact Investigation Coverage**62%86%82%90%9%87%11%-
CURE: High treatment success rate in DS- and DR-TB
7TB Treatment Success Rate***93%93%91%91%95%93%--
8Drug-Resistant TB treatment Success Rate****62%64%69%71%74%---
PREVENT: Prevent TB transmission and development
9TPT Coverage15,41724,67722,468124,70123,33625,39432,50054,369
SUSTAINABLE SYSTEMS: Commitment and sustainability
10Proportion of Domestic Financing for TB 5%4%7%0%3%0%-

*Projected Targets: This represents the United Nations General Assembly High-Level Meeting targets (UNGA targets)
**Contact Investigation Coverage: based on limited available data.
***TB Treatment Success Rate: newest data for 2021 cohort reported.
****Drug-Resistant TB Treatment Success Rate: newest data for 2020 cohort reported.